« Return to News | Awards & Advancement

Sangart appoints three to leadership team

Friday, February 17, 2012 12:43 PM

Sangart, a privately held biopharmaceutical company focused on oxygen-therapeutic agents, has appointed three new members to its executive team.

Frank Booth, MA, MSc, BM, BCh, FACS, was appointed to chief medical officer. Booth has more than 20 years of experience as a trauma and critical care surgeon and as a clinical investigator. Previously he worked in clinical development roles at Novo Nordisk and Eli Lilly.

Mary Rose Keller was appointed vice president of clinical operations, responsible for the execution of all clinical programs, including sickle cell, trauma and future treatments at Sangart. She has more than 25 years of experience in clinical research and trial execution and has been involved with numerous, successful regulatory submissions for companies such as Agouron, Pfizer and Shire Pharmaceuticals.

Carmen Betancourt-Riche, MBA, was appointed vice president of regulatory affairs and quality assurance, overseeing the design and execution of Sangart's global regulatory and quality assurance strategy. She more than 34 years of drug development experience in the pharmaceutical industry and has held senior regulatory roles at BioMarin Pharmaceutical, Cerexa, Coulter Pharmaceuticals, Genentech, KaloBios Pharmaceuticals and VaxGen.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

May 20

IRB consolidation trend continues, as private equity firm Audax buys majority stake in Chesapeake

Quintiles, Merck Serono ink exclusive partnership

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

May

INC Research, PPD, inVentiv named top CROs
Yet most CROs slipping in ability to manage site relationships

R&D cuts by sponsors spur more collaboration, innovation
New strategies share pipeline activity costs

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

April

20 innovators changing the face of the clinical trials industry
The CenterWatch Monthly honors individuals, teams and companies for their forward-thinking ideas and their ability to implement them.

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.